Interestingly, Lu et al. reported that administration of anti-VEGF antibody before the onset of experimental arthritis was able to delay the onset and reduce the severity of disease in the CIA model, whereas administration post-onset of disease had no effect on the progression or severity of the arthritis (Lu et al., 2000). This evidence concerns the gene VEGFA and Arthritis.